EU fines U.S. firm Illumina $475 million for jumping gun on buying cancer-screening company Grail

The European Union on Wednesday slapped a $475 million fine on U.S. biotech giant Illumina for buying out cancer-screening company Grail without the approval of the 27-nation bloc's antitrust watchdog, the latest setback for the deal.

Related Keywords

Brussels ,Bruxelles Capitale ,Belgium ,Washington ,United States ,Margrethe Vestager ,Carl Icahn ,European Commission ,Washington Times ,European Union On ,Microsoft ,European Union ,Commissioner Margrethe ,Federal Trade Commission ,Diego Based Illumina ,